Peritonitis in continuous ambulatory peritoneal dialysis

Journal of the Nepal Medical Association

Volumn 49, Issue 2, 2010, Pages 104-107

  Sharma, Sanjib Kumar ^a   Chaurasia, R K ^a   Sijapati, M J ^a   Thapa, L ^a   Ghimire, M ^a   Shrestha, H ^a   Acharya, A ^a   Khanal, B ^a  

^a B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

Author keywords

Continuous ambulatory peritoneal dialysis; Peritonitis; Peritonitis rate

Indexed keywords

ALBUMIN; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; MALE; PERITONITIS; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ACINETOBACTER INFECTION; ARTICLE; DIABETIC NEPHROPATHY; INCIDENCE; MICROBIOLOGY; MIDDLE AGED; NEPAL; PROSPECTIVE STUDY; PSEUDOMONAS INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION;

ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPAL; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS; SERUM ALBUMIN; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 79958752018     PISSN: 00282715     EISSN: None     Source Type: Journal    
DOI: 10.31729/jnma.107     Document Type: Review

References (22)

1. Whaley-Connell A, Pavey BS, Satalowich R, Prowant BF, Misra M, Twardowski ZJ, Nolph KD, et al. Rates of continuous ambulatory peritoneal dialysis-associated peritonitis at the University of Missouri. Adv Perit Dial. 2005;21:72-5.
2. Finkelstein FO, Abu-Aisha H, Najafi I, Lo WK, Abraham G, Pecoits-Filho R, Suleymanlar G. Peritoneal dialysis in the developing world: recommendations from a symposium at the ISPD meeting 2008. Perit Dial Int. 2009 Nov-Dec;29(6):618-22.
3. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995 Aug;6(2):177-83.
4. Kathleen DL, Glenn MC. Dialysis in the treatment of renal failure. In: Harrison's principle of internal medicine 17th ed. New York: McGraw Hill Medical; 2008. p. 1772-5.
5. Sharma SK, Pahari B, Chaudhary S, Manadhar DN, Acharya PS, Agrawal R, et al. Initiation of Continuous ambulatory peritoneal dialysis in Nepal: Opportunities and Challenges. Indian J of Perit dial. 2009;16:8-11.
6. Sharma SK, Manandhar D, Singh S, Chauhan HS, Koirala B, Gautam M, et al. Acute Peritoneal Dialysis in Eastern Nepal. Perit Dial Int 2003;23(supp2):196-199.
7. Bailie GR, Rasmussen R, Eisele G, Luscombe DK. Peritonitis rates in CAPD patients using the UVXD and O-set systems. Ren Fail. 1993;15(2):225-30.
8. Morse GD, Farolino DF, Apicella MA, Walshe JJ. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother. 1987 Feb;31(2):173-7.
9. Dharmasena D, Roberts DE, Coles GA, Williams JD. Pharmacokinetics of intraperitoneal ciprofloxacin in patients on CAPD. J Antimicrob Chemother. 1989 Feb;23(2):253-9.
10. Paton TW, Manuel A, Cohen LB, Walker SE. The disposition of cefazolin and tobramycin following intraperitoneal administration in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1983;3:73-6.
11. Holley JL, Piraino BM. Complications of peritoneal dialysis: Diagnosis and management. Semin Dial. 1990;3:245-8.
12. Schreiber M, Burkart JM, et al. Peritonitis remains the leading cause of transfer from PD to HD (abstract). Perit Dial Int 1996;16:217.
13. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int. 1997;17:360.
14. Guo A, Mujais S. Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts. Kidney IntSuppl. 2003 Dec;(88):S3-12.
15. Verger C, Luzat MA. In vitro study of CAPD, Y-line systems. Adv CAPD. 1986; 2:160-4.
16. Maiorca R, Cancarini G. Thirty years of progress in peritoneal dialysis. J Nephrol. 1999 Jul-Aug;12 Suppl 2:S92-9.
17. Krishnan M, Thodis E, Ikonomopoulos D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2002;22:573-81.
18. Fielding RE, Clemenger M, Goldberg L, Brown EA. Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin based regimen. Perit Dial Int. 2002;22:345-9.
19. Bailie GR, Rasmussen R, Hollister A, Eisele G. Incidence of CAPD peritonitis in patients using UVXD or O-set systems. Clin Nephrol. 1990 May;33(5):252-4.
20. CAPD peritonitis: Incidence, pathogens, diagnosis, and management. Med Clin North Am 1990 Jul;74(4):997-1010.
21. Fontan MP, Rodriguez-Carmona A, Garcia-Naveiro R, et al. Peritonitis related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005;25:274.
22. Abraham G, Mathew M; Gopalakrishnan P; Sankarasubbaiyan S; Shroff S. Are three exchanges suitable for Asian patients on peritoneal dialysis? Perit Dial Int. 2003;23 Suppl (2):545-7.